Skip to main content
. 2021 Nov 12;10(11):3149. doi: 10.3390/cells10113149

Figure 6.

Figure 6

Therapeutic strategy to restore wild-type activity to mutant p53. Several small molecules have been developed to restore wild-type conformation and function to mutant p53 proteins through covalently binding to cysteines.